Sipuleucel-T and Stereotactic Ablative Body Radiation (SABR) for Metastatic Castrate-resistant Prostate Cancer (mCRPC)
Clinical trial NCT01818986 · COMPLETED
Trial details
- NCT number
- NCT01818986
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-10
- Primary completion
- 2019-12-20
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.